la importancia del tratamiento con células car-t en dlbcl y lcm
Published 2 years ago • 23 plays • Length 3:33Download video MP4
Download video MP3
Similar videos
-
2:41
pbcar0191, un tratamiento car-t alogénico para lla-b
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
1:31
car-t therapy versus autosct in dlbcl
-
0:46
advancements in the dlbcl treatment landscape
-
0:32
las últimas novedades en tratamientos de car-t para lla-b
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
1:29
cd5.car t-cell therapy in patients with t-cell lymphoma
-
2:49
exploring available third-line treatment options for r/r dlbcl: car-t, bispecifics, adcs & mabs
-
1:33
management of relapse after car-t in patients with b-cell lymphoma
-
1:17
the impact of car-t therapy in the second-line setting in lymphoma
-
8:50
an update of car t-cell therapies in lymphoma
-
1:09
optimizing car-t outcomes in dlbcl: possible combination strategies & sequencing of agents
-
1:08
the benefits of car-t therapy in 2l over 3l in r/r dlbcl
-
1:27
il3-zetakine coupled to a cd33 costimulatory receptor as a dual-targeting car approach in aml
-
1:16
predictors of long-term survival in patients with dlbcl/hgbcl following autosct
-
2:04
salvage treatment options following car-t failure in dlbcl
-
2:42
clinical indications for car-t therapy in dlbcl & the possibility of moving car-t into earlier lines
-
0:51
the value of car-t cell therapy in r/r dlbcl